Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
8.21
+0.01 (0.12%)
Jul 18, 2025, 2:45 PM CST
SHE:300636 Revenue
Jiangxi Synergy Pharmaceutical had revenue of 186.90M CNY in the quarter ending March 31, 2025, a decrease of -9.47%. This brings the company's revenue in the last twelve months to 739.33M, up 4.45% year-over-year. In the year 2024, Jiangxi Synergy Pharmaceutical had annual revenue of 758.89M with 5.09% growth.
Revenue (ttm)
739.33M
Revenue Growth
+4.45%
P/S Ratio
4.64
Revenue / Employee
521.39K
Employees
1,418
Market Cap
3.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 758.89M | 36.75M | 5.09% |
Dec 31, 2023 | 722.14M | 2.23M | 0.31% |
Jan 1, 2023 | 719.91M | 127.78M | 21.58% |
Dec 31, 2021 | 592.13M | 156.71M | 35.99% |
Dec 31, 2020 | 435.42M | 22.36M | 5.41% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |